Deutsche Bank’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-30,313
| Closed | -$138K | – | 5674 |
|
|
2019
Q1 | $138K | Buy |
30,313
+2,510
| +9% | +$11.9K | ﹤0.01% | 4186 |
|
|
2018
Q4 | $96K | Sell |
27,803
-93,763
| -77% | -$652K | ﹤0.01% | 4235 |
|
|
2018
Q3 | $1.23M | Sell |
121,566
-3,984
| -3% | -$31.8K | ﹤0.01% | 3176 |
|
|
2018
Q2 | $909K | Buy |
125,550
+32,516
| +35% | +$227K | ﹤0.01% | 3499 |
|
|
2018
Q1 | $560K | Buy |
93,034
+39,207
| +73% | +$324K | ﹤0.01% | 3649 |
|
|
2017
Q4 | $515K | Buy |
53,827
+28,923
| +116% | +$189K | ﹤0.01% | 3583 |
|
|
2017
Q3 | $220K | Sell |
24,904
-65,618
| -72% | -$677K | ﹤0.01% | 3842 |
|
|
2017
Q2 | $1.14M | Buy |
90,522
+24,367
| +37% | +$288K | ﹤0.01% | 2935 |
|
|
2017
Q1 | $693K | Sell |
66,155
-65,224
| -50% | -$695K | ﹤0.01% | 2895 |
|
|
2016
Q4 | $1.21M | Sell |
131,379
-56,727
| -30% | -$641K | ﹤0.01% | 2577 |
|
|
2016
Q3 | $2.22M | Buy |
188,106
+16,963
| +10% | +$258K | ﹤0.01% | 2280 |
|
|
2016
Q2 | $2.21M | Buy |
171,143
+65,035
| +61% | +$948K | ﹤0.01% | 2335 |
|
|
2016
Q1 | $1.7M | Sell |
106,108
-55,448
| -34% | -$1.05M | ﹤0.01% | 2483 |
|
|
2015
Q4 | $4.62M | Buy |
161,556
+41,642
| +35% | +$1.15M | ﹤0.01% | 1848 |
|
|
2015
Q3 | $3.41M | Buy |
119,914
+1,436
| +1% | +$52.9K | ﹤0.01% | 2083 |
|
|
2015
Q2 | $4.25M | Sell |
118,478
-11,502
| -9% | -$358K | ﹤0.01% | 1912 |
|
|
2015
Q1 | $3.78M | Buy |
129,980
+11,310
| +10% | +$299K | ﹤0.01% | 1993 |
|
|
2014
Q4 | $2.5M | Buy |
118,670
+80,848
| +214% | +$1.6M | ﹤0.01% | 2498 |
|
|
2014
Q3 | $732K | Buy |
37,822
+12,148
| +47% | +$191K | ﹤0.01% | 3229 |
|
|
2014
Q2 | $399K | Sell |
25,674
-78,014
| -75% | -$1.26M | ﹤0.01% | 3642 |
|
|
2014
Q1 | $2.15M | Buy |
103,688
+82,043
| +379% | +$1.63M | ﹤0.01% | 2359 |
|
|
2013
Q4 | $279K | Sell |
21,645
-78,207
| -78% | -$1.08M | ﹤0.01% | 3484 |
|
|
2013
Q3 | $1.16M | Sell |
99,852
-59,205
| -37% | -$486K | ﹤0.01% | 2859 |
|
|
2013
Q2 | $732K | Buy |
+159,057
| New | +$583K | ﹤0.01% | 2908 |
|
Other funds holding INSY
WS
Deutsche Bank's INSY Position: Q2 2019 in Review
Deutsche Bank sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 30,313 shares — an estimated $138K sold.
Deutsche Bank first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $4.62M in Q4 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Deutsche Bank reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Deutsche Bank sold 30,313 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $138K.
- Deutsche Bank first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Deutsche Bank's Insys Therapeutics, Inc. position peaked at $4.62M in Q4 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Deutsche Bank's 13F filing for Q2 2019, filed 14 Aug 2019.